Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2468
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorLUNA, Expedito J. A.-
dc.contributor.authorFRAZATTI-GALLINA, Neuza M.-
dc.contributor.authorTIMENETSKY, Maria C. S. T.-
dc.contributor.authorCARDOSO, Maria R. A.-
dc.contributor.authorVERAS, Maria A. S. M.-
dc.contributor.authorMIRAGLIA, Joao L.-
dc.contributor.authorESCOBAR, Ana M. U.-
dc.contributor.authorGRISI, Sandra J. F. E.-
dc.contributor.authorRAW, Isaias-
dc.contributor.authorPRECIOSO, Alexander R.-
dc.date.accessioned2013-09-23T17:02:13Z-
dc.date.available2013-09-23T17:02:13Z-
dc.date.issued2013-
dc.identifier.citationVACCINE, v.31, n.7, p.1100-1105, 2013-
dc.identifier.issn0264-410X-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2468-
dc.description.abstractWe conducted a phase I, double-blind, placebo-controlled trial to evaluate a new 5-valent oral rotavirus vaccine's safety and immunogenicity profiles. Subjects were randomly assigned to receive 3 orally administered doses of a live-attenuated human-bovine (UK) reassortant rotavirus vaccine, containing five viral antigens (G1, G2, G3, G4 and G9), or a placebo. The frequency and severity of adverse events were assessed. Immunogenicity was evaluated by the titers of anti-rotavirus IgA and the presence of neutralizing antibodies anti-rotavirus. No severe adverse events were observed. There was no difference in the frequency of mild adverse events between experimental and control groups. The proportion of seroconversion was consistently higher in the vaccine group, for all serotypes, after each one of the doses. The 5-valent vaccine has shown a good profile of safety and immunogenicity in this small sample of adult volunteers.-
dc.description.sponsorshipButantan Foundation from BNDES [115/08]-
dc.language.isoeng-
dc.publisherELSEVIER SCI LTD-
dc.relation.ispartofVaccine-
dc.rightsrestrictedAccess-
dc.subjectRotavirus-
dc.subjectVaccine-
dc.subjectClinical trial-
dc.subject.otherpolymerase chain-reaction-
dc.subject.othersafety-
dc.subject.otherstrains-
dc.subject.otherbrazil-
dc.subject.otheruk-
dc.subject.otherimmunogenicity-
dc.subject.othercandidates-
dc.subject.otherefficacy-
dc.subject.otherdiarrhea-
dc.subject.otherchildren-
dc.titleA phase I clinical trial of a new 5-valent rotavirus vaccine-
dc.typearticle-
dc.rights.holderCopyright ELSEVIER SCI LTD-
dc.identifier.doi10.1016/j.vaccine.2012.12.020-
dc.identifier.pmid23261048-
dc.subject.wosImmunology-
dc.subject.wosMedicine, Research & Experimental-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalFRAZATTI-GALLINA, Neuza M.:Secretaria Estado Saude Sao Paulo, Inst Butantan, Sao Paulo, Brazil-
hcfmusp.author.externalTIMENETSKY, Maria C. S. T.:Secretaria Estado Saude Sao Paulo, Inst Adolfo Lutz, Sao Paulo, Brazil-
hcfmusp.author.externalCARDOSO, Maria R. A.:Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, BR-05508 Sao Paulo, Brazil-
hcfmusp.author.externalVERAS, Maria A. S. M.:Fac Ciencias Med Santa Casa Sao Paulo, Sao Paulo, Brazil-
hcfmusp.author.externalMIRAGLIA, Joao L.:Secretaria Estado Saude Sao Paulo, Inst Butantan, Sao Paulo, Brazil-
hcfmusp.author.externalRAW, Isaias:Secretaria Estado Saude Sao Paulo, Inst Butantan, Sao Paulo, Brazil-
hcfmusp.description.beginpage1100-
hcfmusp.description.endpage1105-
hcfmusp.description.issue7-
hcfmusp.description.volume31-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84872618781-
hcfmusp.origem.idWOS:000314486900015-
hcfmusp.publisher.cityOXFORD-
hcfmusp.publisher.countryENGLAND-
hcfmusp.relation.referenceCarvalho-Costa FA, 2011, PEDIATR INFECT DIS J, V30, pS35, DOI 10.1097/INF.0b013e3181fefd5f-
hcfmusp.relation.referenceChandran Aruna, 2010, Biologics, V4, P213-
hcfmusp.relation.referenceClements-Mann ML, 1999, VACCINE, V17, P2715, DOI 10.1016/S0264-410X(98)00497-6-
hcfmusp.relation.referenceClements-Mann ML, 2001, VACCINE, V19, P4676, DOI 10.1016/S0264-410X(01)00242-0-
hcfmusp.relation.referencedo Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024-
hcfmusp.relation.referenceEichelberger MC, 2002, J MED VIROL, V66, P407, DOI 10.1002/jmv.2160-
hcfmusp.relation.referenceGENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365-
hcfmusp.relation.referenceGomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071-
hcfmusp.relation.referenceGOUVEA V, 1990, J CLIN MICROBIOL, V28, P276-
hcfmusp.relation.referenceHoshino Y, 1997, J MED VIROL, V51, P319, DOI 10.1002/(SICI)1096-9071(199704)51:4<319::AID-JMV10>3.0.CO;2-D-
hcfmusp.relation.referenceHoshino Y, 2004, J VIROL, V78, P7795, DOI 10.1128/JVI.78.14.7795-7802.2004-
hcfmusp.relation.referenceNakagomi T, 2008, ARCH VIROL, V153, P591, DOI 10.1007/s00705-007-0028-z-
hcfmusp.relation.referenceParashar UD, 2006, SCIENCE, V312, P851, DOI 10.1126/science.1128827-
hcfmusp.relation.referencePatel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756-
hcfmusp.relation.referencePatel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952-
hcfmusp.relation.referenceRichardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211-
hcfmusp.relation.referenceRuiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434-
hcfmusp.relation.referenceSoares-Weiser K, 2010, COCHRANE DB SYST REV, P1-
hcfmusp.relation.referenceTimenetsky MCST, 2005, INT C VIR JOINT M 3-
hcfmusp.relation.referenceVesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664-
hcfmusp.relation.referenceWard Richard L, 2008, Ther Clin Risk Manag, V4, P49-
hcfmusp.relation.referenceWHO, 2007, WHO TECH REP SER, V935, P1-
hcfmusp.relation.reference[Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P220-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipButantan-
hcfmusp.citation.scopus17-
hcfmusp.scopus.lastupdate2024-03-08-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MPE
Departamento de Pediatria - FM/MPE

Artigos e Materiais de Revistas Científicas - HC/ICr
Instituto da Criança - HC/ICr

Artigos e Materiais de Revistas Científicas - IMT
Instituto de Medicina Tropical - IMT

Artigos e Materiais de Revistas Científicas - LIM/21
LIM/21 - Laboratório de Neuroimagem em Psiquiatria

Artigos e Materiais de Revistas Científicas - LIM/52
LIM/52 - Laboratório de Virologia

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_LUNA_A_phase_I_clinical_trial_of_a_new_2013.PDF
  Restricted Access
publishedVersion (English)238.34 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.